Viewing data from:

DODEX

ANDA

CYANOCOBALAMIN | A083022 | ACCORD HEALTHCARE INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Dodex (2023)

Total Spending

$45K

Total Claims

3,713

Beneficiaries

2,748

Avg Cost/Unit

$3.15

Spending Trend

$20K(2022)→$45K(2023)

YoY Change:-8.4%

5yr CAGR:-8.4%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain3 active DMFs5 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

EUROAPI FRANCECYANOCOBALAMIN

DMF 40951981

HEBEI YUXING BIO-ENGINEERING CO LTDCYANOCOBALAMIN

DMF 213912008

HEBEI HUARONG PHARMACEUTICAL CO LTDCYANOCOBALAMIN

DMF 361912021

FARMITALIA SPAInactiveCYANOCOBALAMIN (VITAMIN B 12)

DMF 32221978

SANOFI CHIMIEInactiveCYANOCOBALAMIN PH. EUR. USP, JP

DMF 51381983

ANTIBIOTICE SAInactiveCYANOCOBALAMIN (VITAMIN B12)

DMF 165562003

WOCKHARDT LTDInactiveCYANOCOBALAMIN USP

DMF 197022006

HEBEI HUARONG PHARMACEUTICAL CO LTDInactiveCYANOCOBALAMIN

DMF 209732007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1MG/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.